CTT Pharma adds Karen Larson as independent director

Q: What did CTTH announce about its board?

CTT Pharmaceutical Holdings added Karen Larson as an independent board member.

Q: What qualifications does Karen Larson have?

Larson is a Certified Financial Planner and has experience running companies.

Q: What is Karen Larson's role at Broad Avenue Studios?

Larson has been a founder of Broad Avenue Studios, Inc. since 2017.

Larson's stated background includes financial planning, investment banking, an analytical reporting business sold to Morningstar, and company leadership.

Available on EDGAR 09/23/2026 - 06:01 AM EDT Accepted by SEC EDGAR 09/22/2026 - 06:25 PM EDT

Filing Impact

(High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

CTT Pharmaceutical Holdings, Inc. (CTTH) added Karen Larson as an independent board member. The announcement identifies her as a Certified Financial Planner (CFP) and says she has experience running companies.

Her background includes creating an analytical reporting business that was sold to Morningstar and serving as a Senior Vice President, Investment Banker at Chase Manhattan Bank. She has been a founder of Broad Avenue Studios, Inc. since 2017.

8-K Event Classification

3 items: 1.01, 8.01, 9.01

3 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Start of founder role at Broad Avenue Studios, Inc.: 2017

1 metrics

Start of founder role at Broad Avenue Studios, Inc. 2017 Larson has been a founder since 2017.

Key Terms

Certified Financial Planner(CFP), Senior Vice President, Investment Banker, analytical reporting business

3 terms

Certified Financial Planner(CFP) financial

"is a Certified Financial Planner(CFP)"

Senior Vice President, Investment Banker financial

"served as a Senior Vice President, Investment Banker at Chase Manhattan Bank"

analytical reporting business technical

"created an analytical reporting business"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CTTH announce about its board?

CTT Pharmaceutical Holdings added Karen Larson as an independent board member.

What qualifications does Karen Larson have?

Larson is a Certified Financial Planner and has experience running companies.

What investment and business experience does Karen Larson have?

She created an analytical reporting business that was sold to Morningstar and served as a Senior Vice President, Investment Banker at Chase Manhattan Bank.

What is Karen Larson's role at Broad Avenue Studios?

Larson has been a founder of Broad Avenue Studios, Inc. since 2017.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 10, 2026

CTT PHARMACEUTICAL HOLDINGS, INC.

(Exact Name of Registrant as Specified in Its Charter)

Florida

333-292497

90-1253984

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

1646 W Snow Ave. Suite 138 Tampa, FL 33606

(Address of Principal Executive Offices) (Zip Code)

813-606-0060

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

Name of Each Exchange

on Which Registered

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

Item 8.01 Other Events.

CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has added Karen Larson as an Independent Board Member. Mrs. Larson is a Certified Financial Planner(CFP) and has experience in running companies. Karen created an analytical reporting business that was sold to Morningstar and also served as a Senior Vice President, Investment Banker at Chase Manhattan Bank and since 2017 has spent the past 9 years as a founder of Broad Avenue Studios, Inc., a commercial and residential real company.

Item 9.01 Financial Statements and Exhibits.

(b) Exhibits

Exhibit		Description

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CTT PHARMACEUTICAL HOLDINGS, INC.
	(Registrant)

Date: 9/21/2026	By:	/s/ Ryan Khouri
	Name:	Ryan Khouri
	Title:	Chief Executive Officer (Principal Executive, Financial and Accounting Officer)

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents